Biosimab
- Investor (buy-side or sell-side research)
- Angel Investor Vehicle
- Investing in EU based pharma/medtech/software mostly at seed stage
- Portfolio of 9 companies build up in 2 years
- i.e. Board/Chair of Eleva Biotech, O11 Biomedical, Mo:re - all three represent at Bio US 2025
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}